Natural Products Insider is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CBD market explodes while experts debate regulations

SupplySide West Podcast: CBD market explodes while experts debate regulations

Supplement experts argue about the legal status of cannabidiol (CBD), while consumers have approved the product with their wallets.

Total cannabidiol (CBD) sales in the United States are expected to be $1.9 billion in 2022, with hemp-derived CBD products making up $646 million, marijuana-derived CBD selling $626 million and pharmaceuticals taking the rest at $647 million, according to the Hemp Business Journal. These numbers were presented by Stuart Tomc, vice president of human nutrition, CV Sciences, at the annual Council for Responsible Nutrition (CRN) conference in mid-October 2018. Tomc used these numbers to show the high number of CBD product sales, but also to note that the market splits into three categories: hemp-derived, marijuana-derived and pharmaceuticals. In this podcast with Sandy Almendarez, editor in chief, INSIDER, Tomc, covers:

  • Why the difference in CBD source is important to overcome legal hurdles;
  • The safety of CBD and why his company invested in self-GRAS (generally recognized safe) status for its CBD oil; and
  • Which consumers are taking CBD and where they are buying these products.

Links and resources:

Got feedback? Email Sandy at Sandy.Almendarez@informa.com, or tweet to @NatProdINSIDER using the hashtag #INSIDERPodcast

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish